DK1565207T3 - Plasmaalbuminfraktion med formindsket indhold af prækallikrein - Google Patents

Plasmaalbuminfraktion med formindsket indhold af prækallikrein

Info

Publication number
DK1565207T3
DK1565207T3 DK03767649T DK03767649T DK1565207T3 DK 1565207 T3 DK1565207 T3 DK 1565207T3 DK 03767649 T DK03767649 T DK 03767649T DK 03767649 T DK03767649 T DK 03767649T DK 1565207 T3 DK1565207 T3 DK 1565207T3
Authority
DK
Denmark
Prior art keywords
fraction
precallic
acid
plasma albumin
albumin fraction
Prior art date
Application number
DK03767649T
Other languages
English (en)
Inventor
Werner Gehringer
Katharina Pock
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32337993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1565207(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1565207T3 publication Critical patent/DK1565207T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03767649T 2002-11-25 2003-11-25 Plasmaalbuminfraktion med formindsket indhold af prækallikrein DK1565207T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026165 2002-11-25

Publications (1)

Publication Number Publication Date
DK1565207T3 true DK1565207T3 (da) 2006-08-14

Family

ID=32337993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03767649T DK1565207T3 (da) 2002-11-25 2003-11-25 Plasmaalbuminfraktion med formindsket indhold af prækallikrein

Country Status (23)

Country Link
US (1) US7700732B2 (da)
EP (1) EP1565207B1 (da)
JP (1) JP4532282B2 (da)
KR (1) KR101077651B1 (da)
CN (1) CN100364609C (da)
AT (1) ATE322907T1 (da)
AU (1) AU2003292109B2 (da)
BR (1) BR0316563A (da)
CA (1) CA2506848C (da)
DE (1) DE60304603T2 (da)
DK (1) DK1565207T3 (da)
ES (1) ES2261977T3 (da)
IL (1) IL168506A (da)
MX (1) MXPA05005328A (da)
NO (1) NO330216B1 (da)
PL (1) PL375539A1 (da)
PT (1) PT1565207E (da)
RS (1) RS20050401A (da)
RU (1) RU2321421C2 (da)
SI (1) SI1565207T1 (da)
UA (1) UA77596C2 (da)
WO (1) WO2004047859A2 (da)
ZA (1) ZA200504202B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
SE1050124A1 (sv) 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
GB201317458D0 (en) * 2013-10-02 2013-11-13 Spd Swiss Prec Diagnostics Gmbh Improved pregnancy test device and method
CN107216383A (zh) * 2017-07-13 2017-09-29 同路生物制药有限公司 一种人血白蛋白的制备方法及该人血白蛋白

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378346A (en) * 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4391801A (en) * 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
US6693173B2 (en) * 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins

Also Published As

Publication number Publication date
CA2506848C (en) 2012-09-11
JP4532282B2 (ja) 2010-08-25
NO20052550D0 (no) 2005-05-26
WO2004047859A3 (en) 2004-08-05
IL168506A (en) 2010-11-30
ATE322907T1 (de) 2006-04-15
NO330216B1 (no) 2011-03-07
DE60304603T2 (de) 2007-02-15
KR101077651B1 (ko) 2011-10-27
BR0316563A (pt) 2005-10-04
CA2506848A1 (en) 2004-06-10
NO20052550L (no) 2005-08-12
WO2004047859A2 (en) 2004-06-10
US7700732B2 (en) 2010-04-20
AU2003292109A1 (en) 2004-06-18
JP2006518705A (ja) 2006-08-17
ZA200504202B (en) 2006-02-22
RU2005119987A (ru) 2006-01-20
RU2321421C2 (ru) 2008-04-10
MXPA05005328A (es) 2005-08-16
AU2003292109B2 (en) 2009-02-05
DE60304603D1 (de) 2006-05-24
KR20050085043A (ko) 2005-08-29
SI1565207T1 (sl) 2006-08-31
CN1717249A (zh) 2006-01-04
PL375539A1 (en) 2005-11-28
RS20050401A (en) 2007-06-04
PT1565207E (pt) 2006-07-31
US20060100419A1 (en) 2006-05-11
ES2261977T3 (es) 2006-11-16
EP1565207A2 (en) 2005-08-24
EP1565207B1 (en) 2006-04-12
CN100364609C (zh) 2008-01-30
UA77596C2 (en) 2006-12-15

Similar Documents

Publication Publication Date Title
DK1478394T3 (da) Stabiliseret TNFR-Fc formulation med arginin
DE60239669D1 (de) Sojabohnenprotein, verfahren zu seiner herstellung sowie dessen säure enthaltende proteinnahrungsmittel
ATE331705T1 (de) Alpha-aminosäure-derivate, verfahren zu deren herstellung sowie deren verwendung als dipeptidylpeptidase-iv inhibitoren (dpp iv)
TW200420232A (en) Method for reducing acrylamide formation in thermally processed foods
RS100504A (en) Hepatitis c virus inhibitors
DK239586D0 (da) Fremgangsmaade til transport af levende fisk
ATE307593T1 (de) Mit einem tensid co-mikronisiertes progestin, pharmazeutische zusammensetzung dieses enthaltend,verfahren zu deren herstellung sowie verwendung
IL168506A (en) Method of manufacturing an albumin enriched plasma fraction having reduced prekallikrein activator content
NO20051654L (no) Forlenget frigjoring av farmasoytisk preparat
DK1495023T3 (da) Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse
WO2006071844A3 (en) Oxygen-impervious packaging and methods for storing thyroid hormone
NO20031251D0 (no) Fremgangsmåte for fremstilling av små soyabaserte måltid med lavt fett- oghöyt proteininnhold
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
PE20040703A1 (es) Derivados aldehido de polietilenglicol
NO20041212L (no) Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.
ATE362322T1 (de) Kaffeezusammensetzungen mit stabilen aromaeigenschaften und verfahren zu deren herstellung
DK1329460T3 (da) Fremgangsmåde til monomerisering af polymerer af humant serum albumin
DE60141918D1 (de) Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd)
ATE404545T1 (de) Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid
WO2003059286A3 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
DE60100388D1 (de) Aminosäurederivate und deren verwendung als inhibitoren von nep, ace und ece
DE60137862D1 (de) Verfahren zur rückgewinnung von hexamethylendiamin (hmd) mit geringem polarographischen reduzierbaren verunreinigungen (prv) aus gemischen enthaltend hmd, aminocapronitril und prv
AU2003281663A1 (en) Method to overcome instability of ultra-shallow semiconductor junctions
DE69103042T2 (de) Angiotensin-konvertierender Enzym-Inhibitor, Verfahren zu seiner Herstellung, diesen enthaltende Zusammensetzung und deren Verwendung.
CY1111115T1 (el) Μουσκαρινικοι αγωνιστες